H igh blood pressure (BP) is the leading risk factor of cardiovascular disease and deaths globally. 1-3 Sudden cold stress is known to activate the sympathetic nervous system, resulting in vasoconstriction and subsequent increases in BP. 4 The cold pressor test (CPT), which measures BP response to external cold stimulus, has been commonly used to assess cardiovascular reactivity. 5, 6 Previous studies indicate that BP response to CPT is a stable and reproducible trait in the general population. 7 Furthermore, elevated BP responses to CPT have been associated with increased risk of hypertension and cardiovascular disease. [8] [9] [10] 
to 35% in the Han Chinese population. [11] [12] [13] [14] Although some studies have been conducted to identify the genetic mechanisms underlying this complex phenotype, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] most of the genomic research has been hypothesis driven [16] [17] [18] [19] [20] [21] [22] [23] [24] and performed among participants of European ancestry. [15] [16] [17] [18] [19] [20] [21] The aim of the current study was to identify chromosomal regions harboring novel quantitative trait loci for systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) responses to CPT by conducting a genome-wide linkage scan among Han Chinese participants of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) study. To localize signals identified by the genome-wide scans, we genotyped a dense panel of single nucleotide polymorphisms (SNPs) located in promising linkage regions and conducted both single-marker and gene-based association analyses of the BP response phenotypes.
Methods

Study Participants
The GenSalt study is a unique dietary feeding study designed to examine gene-dietary sodium and potassium interactions on BP. The GenSalt study includes 3142 Han Chinese participants from rural north China. A detailed description of the study design and participants has been presented elsewhere. 26 Briefly, a community-based BP screening was conducted among patients aged 18 to 60 years in the study villages to identify potential probands. Those with a mean SBP between 130 and 160 mm Hg, a DBP between 85 and 100 mm Hg, and no use of antihypertensive medications were recruited for the study, as well as their siblings, offspring, parents, and spouses. Individuals who had stage-2 hypertension, secondary hypertension, clinical cardiovascular disease, chronic kidney disease, or diabetes mellitus; who used antihypertensive medications; or who were pregnant, heavy alcohol drinkers, or currently on a low-sodium diet were excluded from the study. After additional exclusion of participants aged ≥60 years, a total of 1961 participants from 631 families were eligible for and completed the CPT. These 1961 participants also underwent microsatellite marker genotyping and were included in the genome-wide linkage analysis. Among them, 1783 (90.9%) were genotyped for SNPs located under promising linkage regions and were included for further association analyses.
Institutional review boards at all of the participating institutions approved the study protocol. Written informed consents were obtained from each participant.
Data Collection and CPT Measurement
A standard questionnaire was administered by a trained staff member to collect information on family pedigree, demographic characteristics, personal and family medical history, and lifestyle risk factors. Body weight and height were measured twice in light indoor clothing without shoes. Body mass index was calculated as weight in kilograms per height in square meters.
The CPT was conducted during the baseline examination. BP measurements were obtained by a trained and certified technician using a standard mercury sphygmomanometer. Each participant was advised to avoid alcohol, coffee/tea, cigarette smoking, and exercise for ≥30 minutes before the CPT. After the participant had remained sitting for 20 minutes, 3 BP measurements were obtained and the mean was calculated as an estimate of the pretest BP. Then the participant immersed his or her left hand in the ice-water bath (3-5°C) to just above the wrist for 1 minute. After the left hand had been removed from the ice-water bath, BP measurements were obtained at 0, 1, 2, and 4 minutes. The CPT was tolerated by all the subjects, and no adverse effects were reported. Because ≥80% of participants achieved maximum change in BP at 0 minute after the ending of ice-water immersion, 14 BP responses to CPT were defined as the BP at 0 minute minus pretest BP.
Microsatellite Marker Genotyping
Lymphocytic DNA samples were obtained from all 3142 GenSalt family members (probands, siblings, offspring, parents, and spouses) and used for genotyping microsatellite markers spaced at ≈9-cM intervals (359 markers, Marshfield Screening Set 12). Fluorescently labeled polymerase chain reaction primers were used for marker amplification followed by capillary electrophoresis on automated DNA sequencers (ABI 3730 DNA Analyzer; Applied Biosystems, Carlsbad, CA). Quality control samples included blind duplicates, no DNA controls, and Centre d'Etude du Polymorphisme Humain DNA standards. Genotypes were assigned using Gene Mapper software (Applied Biosystems). Affected Sib-Pair Interval Mapping and Exclusion 27 and Graphical Representation of Relationships 28 softwares were used to check for potential misreported relationships in the GenSalt pedigrees. PedCheck 29 and MapMaker/Sibs 30 were used to examine Mendelian inconsistencies within families for each marker.
SNP Genotyping
SNPs located in promising linkage regions (logarithm of odds [LOD], ≥2) were genotyped using chip-based hybridization assays (Affymetrix 6.0, Inc, Santa Clara, CA) among a subsample of 1783 probands, siblings, offspring, and spouses who took part in both the CPT measurement and the GenSalt dietary intervention (described elsewhere). 26 A total of 1646 SNPs were identified under the promising linkage region at 20p13 to 20p12.3. After the exclusion of 287 SNPs with a minor allele frequency <0.01, 7 SNPs with a genotyping call rate <90%, 1 SNP that significantly deviated from Hardy-Weinberg equilibrium after adjustment for multiple comparisons (false discovery rate [FDR], P<0.05), and a total of 1,351 SNPs meeting the quality control criteria remained in the analysis.
Statistical Analysis
Genome-Wide Linkage Analysis
The mean or percentage of each baseline characteristic and BP response variable was calculated for the study participants. Before linkage analysis, multipoint identity by descent estimates were calculated using Merlin software. 31 Multipoint quantitative trait linkage analysis was conducted using Sequential Oligogenic Linkage Analysis Routines software. 32 The robust LOD score was obtained using 10 000 replicates and simulation methods (−lodadj option) in Sequential Oligogenic Linkage Analysis Routines. A LOD score ≥2.0 was considered as suggestive evidence of linkage. Phenotypes were adjusted for age, sex, body mass index, and field center.
Single SNP Association Analysis
Additive associations between single SNPs in promising linkage regions and BP responses to CPT were assessed using a mixed linear regression model. Because most of the studied families only included sib pairs, we selected compound symmetry as the covariance structure, which assumes the same degree of dependency among family members. We used the asymptotically consistent sandwich estimator to compute the estimated variance-covariance matrix of the fixedeffects parameters (eg, genetic effect coefficient). 33 Age, sex, body mass index, and field center were adjusted in multivariable analyses. The FDR P value was calculated to adjust for multiple testing. 34
Gene-Based Association Analysis
To be selected for gene-based analyses, genes had to meet the following criteria: (1) ≥1 SNP in the gene or its ±5-kb flanking region fell within the promising linkage region and (2) the gene must have proteincoding ability. After excluding 31 pseudogenes and RNAs, 46 genes located within the observed linkage peaks were eligible for gene-based association analysis. Gene-based associations were examined using the truncated product method (TPM). 35 The TPM has been evaluated extensively by simulation studies, 36 and its application to determine genebased associations was described recently. 37 Briefly, the TPM combines P values from a set of L hypothesis tests (eg, all association tests in a gene). TPM estimates a test statistic based on the product of all P values below a prespecified threshold (τ), evaluating the probability of such a product under the overall hypothesis that all L hypotheses are true. In our analysis, to take linkage disequilibrium (LD) patterns into account, 767 tag-SNPs among the 1351 SNPs were selected using pairwise r 2 <0.8 based on LD structure in the sample. P values of the 767 tag-SNPs from single-marker analyses were used in the TPM. The truncation point was set as τ=0.1 based on simulation studies, indicating that a smaller truncation point may be preferable to reduce type I error. 38 The P value for TPM was estimated by 100 000 simulations. The FDR P value was calculated to adjust for multiple comparisons. Furthermore, sensitivity analyses were conducted to examine the relative contribution of each SNP to significant gene-based signals. Each SNP was consecutively removed from the gene-based analysis, and the new gene-based P value was calculated including SNPs but the excluded one. Analyses were done using SAS version 9.2 (SAS Institute, Cary, NC) and R version 2.15.2 (www.r-project.org) software.
Results
The 1961 participants who completed CPT consisted of 636 probands, 921 siblings, 191 offspring, 154 parents, and 59 spouses. The baseline characteristics of study participants are presented in Table 1 . The average age ranged from 23.3 years among offspring to 55.5 years among parents. When compared with pretest BP levels, mean BP increased at 0 minute after the CPT among study participants. For example, the absolute SBP, DBP, and MAP responses to CPT were 14.8, 7.0, and 9.6 mm Hg, respectively, among the study probands. All BP responses to CPT phenotypes were normally distributed.
The genome-wide linkage results for BP responses to CPT are illustrated in Figure 1 . Suggestive linkage (LOD≥2.0) of SBP response to the CPT was identified at chromosomal region 20p13 to 20p12.3, with a maximum multipoint LOD score of 2.37 at 20p13. Maximum multipoint LOD scores for DBP and MAP responses in this region were 0.12 and 1.38, respectively. No additional linkage peaks were identified by the current study. Figure 2 shows the association between 1351 SNPs in 20p13 to 20p12.3 and BP responses to CPT. Marker rs2326373 (minor allele frequency, 2.4%; call rate, 100%; and P HWE =0.31), which is located 43 kb upstream of the SMOX gene, was significantly associated with MAP responses to CPT after using FDR correction for multiple comparisons (P=8.8×10 −6 ; FDR P=0.01). The association of rs2326373 with DBP response to CPT was marginally significant after FDR adjustment (P=4.6×10 −5 ; FDR P=0.06). MAP responses (95% confidence interval) for genotypes G/G, G/A, and A/A were 8.97 (8.56-9.38), 6.48 (5.27-7.69), and 3.92 (2.80-5.03) mm Hg, respectively, and DBP responses (95% confidence interval) were 6.83 (6.44-7.23), 4.11 (2.83-5.40), and 4.22 (3.13-5.32) mm Hg, respectively. A similar trend was also observed for SBP response although it was not significant after FDR adjustment for multiple testing ( Table 2) .
The 46 genes examined in gene-based analyses are shown in Figure 2 . Table 3 presents results of the gene-based analyses. Although none of the individual variants within the 46 genes examined were significant after adjustment for multiple testing in single-marker analyses (exact P values are shown in Table I in the Data Supplement), gene-based analyses revealed strong associations of MCM8 and SLC23A2 with SBP response to CPT (P=4.0×10 −5 and 2.7×10 −4 , respectively). In addition, variants in genes MCM8 and STK35 were overall associated with MAP response to CPT (P=1.5×10 −5 and 5.0×10 −5 , respectively).
Sensitivity analyses revealed several SNPs that seemed to contribute significantly to the gene-based signals for STK35, SLC23A2, and MCM8 (Tables II-IV in the Data Supplement) . For example, after excluding marker rs6137005, the P value for the association between STK35 and MAP response to CPT was no longer significant after adjustment for multiple testing, decreasing from 5.0×10 −5 to 3.7×10 −3 ( Table II in 
Discussion
In the first genome-wide linkage scan of the BP response to CPT phenotype conducted in an East Asian sample, we identified suggestive linkage at 20p13 to 20p12.3. Within the identified linkage region, a novel, low-frequency intergenic variant, rs2326373, showed strong and consistent associations with SBP, DBP, and MAP responses to CPT. Although no genic variant achieved significance after adjustment for multiple testing in single-marker analysis, gene-based analyses of such variants revealed strong associations between the MCM8, SLC23A2, and STK35 genes and BP responses to CPT. These findings represent some of the first non-hypothesis-driven genomic research of the BP response to CPT phenotype, implicating novel genetic mechanisms influencing this complex trait. Furthermore, our report highlights the importance of considering genetic effects at both the SNP level and the gene level to elucidate the genetic architecture of complex phenotypes, such as BP response to CPT.
In the current genome-wide linkage analysis, we identified suggestive linkage signals for SBP response to CPT at 20p13 to 20p12.3. Our study represents the first genome-wide linkage scan of this unique phenotype in the Chinese population. Only one other linkage scan was conducted previously in an Arabic population but did not identify any suggestive linkage signals. 15 Although previous linkage scans have not linked this region at 20p13 to 20p12.3 to the correlated BP or hypertension phenotypes, this region was linked to asthma, 39 a trait that has been tied previously to both autonomic-cardiovascular control 40 and BP response to CPT. 41 Although further research in this area is needed, these findings suggest a potentially shared genetic basis for cardiovascular and respiratory autonomic functions.
Follow-up association analysis in the linkage region identified a significant association between SNP rs2326373 and MAP responses to CPT. Marker rs2326373 is an intergenic variant located 43 kb upstream of its nearest gene, spermine oxidase (SMOX). Although no clear functional role of SMOX has been found in BP regulation, 42 it has been reported that the level of spermine oxidase encoded by SMOX increases in the plasma of patients with stroke, 43 an important BP-related phenotype. 44 This low-frequency variant rs2326373 demonstrated a relatively large effect on the BP responses to CPT phenotypes. For example, those homozygous for the minor A allele had MAP responses to the CPT that were an average of 5 mm Hg smaller than those homozygous for the major G allele. Although the minor allele frequency was only 2.4% in the Han Chinese GenSalt sample, this variant has minor allele frequencies of 15% and 29% in samples of European and African ancestry, respectively. 45 These data indicate that rs2326373 could be particularly relevant at the population level in these groups. Because rs2326373 is not in LD with any known functional variants, resequencing followed by experimental studies will be warranted to determine the causal variant underlying the strong signal observed in the current analysis.
Gene-based analyses showed that the STK35, SLC23A2, and MCM8 genes were strongly associated with BP responses to CPT. These data provide empirical evidence that the overall effect of multiple SNPs within a gene may be substantial even in the absence of significant single-marker associations. For instance, there were no SNPs within MCM8 that individually associated with BP responses to CPT after adjusting for multiple testing. However, the overall effect of all 6 tag-SNPs within this gene revealed highly significant associations with SBP and MAP responses (P=4.0×10 −5 and 1.5×10 −5 , respectively), even after FDR correction for multiple comparisons. Although sensitivity analyses revealed several markers that seemed to contribute substantially to these 3 significant gene-based signals, bioinformatics analysis did not suggest functional relevance for the identified variants. Future fine-mapping studies of these genes may provide important information toward identifying the causal variants underlying the observed signals.
Despite the strong associations observed in the gene-based analysis, little is known about the biological pathways by which the MCM8, SLC23A2, and STK35 genes or their products influence BP regulation. For example, the MCM8 gene encodes a minichromosome maintenance protein involved in DNA replication initiation and elongation and has no known role in BP response to CPT. 46 The SLC23A2 gene encodes the sodium-dependent vitamin C transporter 2, an essential transporter for tissue-specific uptake of vitamin C, which prevents oxidative damage to the cardiovascular system by sequestering free radicals. 47 STK35 encodes a serine/threonine protein kinase linking the cell cycle and migration of endothelial cells. 48 Although additional studies are warranted to elucidate the biological mechanisms of these genes, these data support the opinion that gene-based approaches may play a key role in identifying novel genetic mechanisms that could be missed by relying on single-marker methods of analysis. 37, 49 There are several strengths of our study. Because microsatellite markers were genotyped for all 3142 family members and multipoint methods were used in the analysis, the current study had increased power to detect linkage signals. In addition, homogeneity of the population with respect to lifestyle risk factors minimized the confounding effects of environment on genotype-phenotype associations. The recruitment of all Han Chinese participants with little ethnic admixture should make the association analysis robust to population stratification. Furthermore, stringent quality control procedures were used during genotyping, data cleaning, and measurements of BP and other covariates.
Still, potential limitations should be addressed. Adjustment for marker rs2326373 could not explain the linkage signal at 20p13 to 20p12.3 (data not shown). Although our genotyping platform should provide good coverage of common genetic variants in the linkage region, 50 some important low-frequency, rare, and structural variants, as well as gene-gene or gene-environment interactions, may be missed by the current study. Moreover, the TPM statistics for gene-based analysis do not take gene size into account. Although larger genes may have stronger TPM P values because of more SNPs in LD in larger genes, we used tag-SNPs to minimize bias because of LD patterns in a gene. Among the gene-based signals, gene sizes for STK35 and MCM8 were relatively average (56.7 and 54.5 kb, respectively), and the number of tag-SNPs used in the 2 gene-based tests were few (8 and 6, respectively). These data suggest that gene size was unlikely to influence study findings. Data for only 1 tag-SNP were available within each of the following genes: SNRPB, GNRH2, SLC4A11, and PCNA (Table 3) . Therefore, information from the genebased tests for these genes should be interpreted with caution. Furthermore, replication work will be required to confirm the SNP-based and gene-based associations. In summary, the current study described a genetic region on chromosome 20 that may harbor important susceptibility loci for BP response to CPT. Within the linkage region, low-frequency variant rs2326373 showed strong and consistent associations with SBP, DBP, and MAP responses. In addition, there were significant gene-based associations of MCM8, SLC23A2, and STK35 with BP responses to CPT. These findings provide some of the first non-hypothesis-driven evidence of novel genetic mechanisms underlying BP response to CPT. In addition, we highlight the potential importance of gene-based analyses for elucidating the genomic architecture of complex phenotypes, such as BP response to CPT. Additional studies are warranted to replicate our results and to pinpoint the causal, functional variants underlying the strong signals reported here.
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